Foghorn Therapeutics (FHTX) Q4 2021 Earnings Report

449 Followers

FHTX Q4 2021 EPS Results

Actual EPS-$0.77

Consensus EPS-$0.74

Beat/MissMissed by -$0.03

One Year Ago EPS-$0.86

Actual Revenue$713.00K

Expected Revenue$710.00K

Beat/MissBeat by +$3.00K

YoY Revenue Growth―

QuarterQ4 2021

Date03/10/2022

TimeTBA

Conference CallThursday, March 10, 2022

FHTX Upcoming Earnings

Foghorn Therapeutics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-0.25 / -	-0.25	―
Aug 06, 2026	2026 (Q2)	-0.24 / -0.10	-0.28	64.29% (+0.18)
May 07, 2026	2026 (Q1)	-0.30 / -0.29	-0.3	3.33% (+0.01)
Mar 11, 2026	2025 (Q4)	-0.26 / -0.35	-0.23	-52.17% (-0.12)
Nov 05, 2025	2025 (Q3)	-0.33 / -0.25	-0.31	19.35% (+0.06)
Aug 05, 2025	2025 (Q2)	-0.35 / -0.28	-0.45	37.78% (+0.17)
May 14, 2025	2025 (Q1)	-0.31 / -0.30	-0.59	49.15% (+0.29)
Mar 06, 2025	2024 (Q4)	-0.31 / -0.23	-0.57	59.65% (+0.34)
Nov 04, 2024	2024 (Q3)	-0.43 / -0.31	-0.34	8.82% (+0.03)
Aug 08, 2024	2024 (Q2)	-0.64 / -0.45	-0.7	35.71% (+0.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed